First Time Loading...

Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 18.16 CNY 0.33% Market Closed
Updated: Jun 1, 2024

Shanghai Pharmaceuticals Holding Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shanghai Pharmaceuticals Holding Co Ltd
Total Equity Peer Comparison

Comparables:
1099
600998
C
600511
000963
C
000028

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Total Equity
¥68.5B
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
10%
Sinopharm Group Co Ltd
HKEX:1099
Total Equity
¥69.6B
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
12%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Total Equity
¥24B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
13%
C
China National Medicines Corp Ltd
SSE:600511
Total Equity
¥15.8B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
22%
Huadong Medicine Co Ltd
SZSE:000963
Total Equity
¥21B
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
22%
C
China National Accord Medicines Corp Ltd
SZSE:000028
Total Equity
¥17.4B
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
15%

See Also

What is Shanghai Pharmaceuticals Holding Co Ltd's Total Equity?
Total Equity
68.5B CNY

Based on the financial report for Mar 31, 2024, Shanghai Pharmaceuticals Holding Co Ltd's Total Equity amounts to 68.5B CNY.

What is Shanghai Pharmaceuticals Holding Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
10%

Over the last year, the Total Equity growth was 0%. The average annual Total Equity growth rates for Shanghai Pharmaceuticals Holding Co Ltd have been 13% over the past three years , 11% over the past five years , and 10% over the past ten years .